Skip to main content
NPCE
NASDAQ Life Sciences

NeuroPace Halves as Guidance Cut and Q3 Revenue Miss Hit Largest Accounts

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$5.92
Mkt Cap
$412.578M
52W Low
$5.46
52W High
$19.6
52W Position info
8.4% above low
Off High info
70% below high
Rel. Volume info
16× avg
Market data snapshot near publication time

NPCE is trading near its 52-week low of $5.46 (8.4% above the low) on elevated volume (16× avg).

Summary

Shares fell 52% to $5.83 late Friday morning, extending the year-to-date decline to 62%, after NeuroPace cut full-year 2026 revenue guidance to $91-92 million from $99.5-101.5 million. The cut follows Q3 revenue of $23.1 million, down from $23.4 million a year earlier and well short of the $27.1 million FactSet consensus. CEO Joel Becker attributed the shortfall to isolated issues concentrated in several of the company's largest accounts, compounded by field organization changes that caused more disruption than anticipated. The Q3 loss was $3.3 million, or 10 cents a share, versus 11 cents expected, so the miss is a revenue and account-concentration problem rather than a cost problem. The 10-Q filed Nov 12 shows $49.2 million of cash against $59.2 million of debt, leaving limited cushion if the account issues persist into Q4.

At the time of this announcement, NPCE was trading at $5.92 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $412.6M. The 52-week trading range was $5.46 to $19.60. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

NPCE - Latest Insights

NPCE
Nov 12, 2026, 4:38 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $7.84
Real-time Price: $6.63 info
Change: -$1.21 (-15%) info
Market Cap: $227.57M info
NPCE
Nov 12, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $12.02
Real-time Price: $6.63 info
Change: -$5.39 (-45%) info
Market Cap: $227.57M info
NPCE
Aug 11, 2026, 4:33 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $15.03
Real-time Price: $6.63 info
Change: -$8.40 (-56%) info
Market Cap: $227.57M info
NPCE
Aug 11, 2026, 4:23 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $15.03
Real-time Price: $6.63 info
Change: -$8.40 (-56%) info
Market Cap: $227.57M info
NPCE
Aug 11, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $15.03
Real-time Price: $6.63 info
Change: -$8.40 (-56%) info
Market Cap: $227.57M info